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SUMMARY
Milk sugar is composed of glucose and galactose. Galactose is less suitable as an energy source than
glucose. Thus, it has been a puzzle as to why mammals utilize galactose as a major component of milk
sugar. Here we show that in hypoglycemic conditions, the presence of a trace amount of galactose,
but not glucose, is able to maintain the production of mature glycoproteins and to abolish cell-
death-inducing endoplasmic reticulum stress. In severely sugar-limited conditions, both glucose
and galactose enter into the glycolytic pathway, but galactose is not able to raise the phosphofructo-
kinase 1 activity, leading to the accumulation of fructose-6-phosphate, which in turn is utilized for the
maturation of glycoproteins (e.g., growth factor receptors) and allows the activation of their intracel-
lular signaling and prevents cell death from hypoglycemic conditions. Thus trace amounts of galactose
may play unexpectedly important roles in the growth of infants and their protection during starvation.
INTRODUCTION
Maintenance of glucose levels is of great physiologic importance, and imbalances lead to an array of detri-
mental effects. Reduced glucose levels cause symptoms ranging frommild discomfort to severe confusion,
seizures, and ultimately, brain damage (Agrawal et al., 2014). At the cellular level, glucose is mostly utilized
as an energy source and is also required for protein glycosylation, which serves a variety of structural and
functional roles in membrane-bound and secreted proteins. Glycosylation is a major form of protein modi-
fication in eukaryotes. It has been estimated that approximately half of all human proteins are glycosylated
andmost containN-glycan structures (Apweiler et al., 1999). High-mannose-typeN-glycans are reported to
constitute approximately 40% of all N-glycans in mouse brains (Ishii et al., 2007). Furthermore, it is well
known that N-glycosylation improves protein stability and regulates the function of cytokines and chemo-
kines (Opdenakker et al., 1995). Hence, protein glycosylation plays very important roles for protein homeo-
stasis and function.
Sugar insufficiency is oneof the leading causesof endoplasmic reticulum (ER) stress. Cells copewithER stress via
three types of ER stress sensors and respondbydeploying the unfoldedprotein response (UPR). The sensors are
PKR-like ER kinase (PERK), inositol-requiring enzyme 1a (IRE1a), and activating transcription factor 6 (ATF6).
Following theactivationof thesesensors, different signalingnodes, suchasc-JunN-terminal kinase1, anddown-
stream transcription factors, such as X-box-binding protein 1 (XBP1), activating transcription factor 4 (ATF4), and
C/EBP homologous protein (CHOP), are activated (Mori, 2009). For example, IRE1a is activated by self-phos-
phorylation and manifests endoribonuclease activity, which cleaves a cryptic 26-bp exon from the downstream
target XBP1mRNA. The resulting unconventionally spliced mRNA encodes an alternate XBP1 protein, spliced
XBP1 (XBP1s), which is a highly active transcription factor that promotes the expression of ER chaperones and
molecules involved in ER-associated degradation (Yoshida et al., 2001). Notably, XBP1s-dependent activation
of the hexosamine biosynthetic pathway (HBP), which converts glucose to uridine 50-diphosphateN-acetylglu-
cosamine (UDP-GlcNAc) forN- andO-glycosylation of proteins, has been reported to protect cells from various
biological insults, such as ER stress and cardiac ischemia/reperfusion injury (Wang et al., 2014). Hence, XBP1s is
particularly important for cell survival.
Most studies of mammalian sugar metabolism concentrate on glucose, owing to its central roles in not only
energy generation but also protein glycosylation. Other hexoses, e.g., mannose and galactose, receive
relatively little attention in metabolic and physiologic studies. Mannose is a C2 epimer of glucose and
is naturally found in microbes, plants, and animals. Free mannose is found in mammalian plasma at
50–100 mM (Alton et al., 1998). Galactose is a C4 epimer of glucose. Galactose, which is of particular
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relevance to mammals, is mostly produced by hydrolysis of the milk sugar lactose, a disaccharide with
a glycosidic linkage between glucose and galactose. Free galactose concentrations in plasma are
usually <10 mg/dL (0.56 mM) (Kaempf et al., 1988). The detectable plasma galactose levels in normal adult
humans suggest that the dietary acquisition of modest amounts of galactose from fruits and vegetables,
e.g., tomatoes, bell peppers, brussels sprouts, apples, bananas, persimmons, dates, etc., (Gross and
Acosta, 1991) is beneficial. Galactose is metabolized by the enzymes of the Leloir pathway in the liver
(Frey, 1996), which requires several enzymes to convert galactose to glucose-6-phosphate (G6P). In mam-
mals, mutations in some of these enzymes can result in the genetic disease galactosemia (Leslie, 2003;
Holden et al., 2004; Timson, 2006). Despite such disadvantageous features of galactose, mammals must
use galactose for something important, because lactose, the milk sugar, consists of galactose and glucose
as a heterodimer. Based on the evidence that lactose is an essential nutrient for mammalian babies, one of
the biggest and long-lasting questions in biology has been why galactose has been evolutionally selected
as a major component of lactose.
RESULTS
Galactose Promotes N-Glycosylation Preferentially over Glucose or Mannose
Sugar deprivation induces immature N-GlcNAc2-modified glycoproteins, which cross-react with the
O-GlcNAc-specific antibody CTD110.6 (Isono, 2011). We also independently observed that HEK293 cells
produced proteins recognized by CTD110.6 antibody under sugar deprivation and that ER stress was
evident under this condition (Figure 1A). We successfully identified laminin g1 and laminin b2 as
CTD110.6-antibody-recognized proteins, by immunoprecipitation with CTD110.6 antibody, followed by
liquid chromatography-tandem mass spectrometry analyses (Figures S1A and S1B). Both of these are
N-linked high-mannose-type glycoproteins (Fujiwara et al., 1998). Indeed, CTD110.6 antibody recognized
only lower-molecular-weight or immature forms of laminin g1 and laminin b2, which appeared only upon
sugar starvation. We also showed that an anti-laminin g1 antibody revealed aggregate-like structures in
cells under sugar starvation, most likely in the ER (Ikeda et al., 2014). Pulse-chase experiments using [35S]
methionine/cysteine indicated thatN-GlcNAc2-modified laminin b2 was a newly synthesized protein rather
than a cleavage product of mature N-glycosylated laminin b2 (Figure S2). Addition of varying amounts of
glucose in a dose- and time-dependent manner eliminated these immature glycoproteins and ER stress
(Figures 1B and S1C). These results clearly indicated that sugar-deprivation-induced ER stress is correlated
with the accumulation of immature glycoproteins in the ER.
To elucidate the role of other hexoses in protein glycosylation, we then focused on mannose and galac-
tose and examined how these sugars function in producing mature N-glycosylated proteins, when
compared with glucose. Mannose showed an essentially identical capacity as glucose with regard to
the production of mature N-glycosylated proteins and the reduction of ER stress (Figure 1C). Surpris-
ingly, however, galactose was 10 times more effective at producing mature N-glycosylated proteins
and canceling ER stress (Figure 1D). In other words, 0.3 mM galactose was just as effective as 3 mM
glucose or 3 mM mannose in the production of mature N-glycosylated proteins and abatement of ER
stress (Figures 1B–1E). Furthermore, both 0.3 mM galactose (Figure 1F) and 3 mM glucose (Figure S1C)
led to mature laminin g1 production over a similar time course. We also observed that galactose had the
same robust ability to produce mature N-glycosylated proteins and to reduce ER stress in other cell lines,
including human hepatoblastoma-derived HepG2 cells and rat pheochromocytoma-derived PC12 cells
(Figure S3).
Sugar Deprivation Increases the Expression of Enzymes Involved in N-Glycosylation via
XBP1s
Activated nucleotide sugars, such as UDP-GlcNAc and guanosine diphosphate mannose (GDP-Man),
which are required for N-glycosylation, are derived from fructose-6-phosphate (F6P) (Dennis et al.,
2009). We therefore speculated that cellular mechanisms should exist to compensate for the glycosylation
failure under sugar deprivation. Based on such speculation, we performed qRT-PCR analyses on mRNAs of
glycolytic pathway enzymes and observed the upregulation of HK2, ALDO, and ENO4mRNAs in response
to sugar deprivation (Figure 2A). We also observed upregulation of mRNAs forGFAT1 andGMPP (A and B),
which are responsible for the production of UDP-GlcNAc and GDP-Man, respectively (Figures 2B and 2C)
(Dennis et al., 2009; Szumilo et al., 1993; Ning and Elbein, 2000). mRNA for STT3A, but not for STT3B, both
of which encode catalytic subunits of the N-oligosaccharyltransferase (OST) complex (Kelleher et al., 2003;
Ruiz-Canada et al., 2009), was also upregulated (Figure 2C). Protein levels of HK2, GFAT1, GMPPA, and
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GMPPB were also increased by sugar deprivation (Figure S4). Subsequently, we tested whether other ER
stress inducers, e.g., thapsigargin and brefeldin A, produced similar effects and found that HK2, GFAT1,
GMPPA, GMPPB, and STT3A mRNAs and the corresponding proteins increased (Figure S5).
Under ER stress, ATF4, ATF6, and XBP1 function as transcription factors to upregulate their target genes to
cope with the ER-stress-inducing conditions; the induction of these specific target mRNAs constitutes part
of the UPR (Walter and Ron, 2011). We examined whether overexpression of these transcription factors
would alter the expression of the same genes that were upregulated during sugar deprivation. We found
that overexpression of the ER-stress-related XBP1s led to increases in transcription of all the above-
mentioned genes that were upregulated during sugar deprivation (Figure 2D); overexpression of ATF4,
but not ATF6, just slightly increased the abundance ofHK2 andGFAT1mRNAs (Figure 2D). Overexpression
of ATF4 or ATF6 increased the expression of XBP1mRNA in the glucose(+) condition (Figures S6A and S6B)
(Yoshida et al., 2001; Tsuru et al., 2016). However, overexpression of ATF4, but not ATF6, induced IRE1a
protein (Figure S6C), and the former, but not the latter, marginally induced the unconventional splicing
Figure 1. Galactose Promotes N-Glycosylation Preferentially over Glucose or Mannose
(A) HEK293 cells were deprived of glucose for 24 hr. Total cell lysates were analyzed by western blot with CTD110.6 to
assess N-glycosylation levels and an antibody against CHOP as an ER stress marker.
(B–D) The promoting effect of glucose (B), mannose (C), or galactose (D) for N-glycosylation. Each immunoblot is
represented by laminin g1, CTD110.6, CHOP, and GRP78.
(E) Quantitative analysis of reactivity with CTD110.6 antibody in (B–D), normalized to actin intensity. The value for the
sugar-free condition was set as 1. The data are the meanG SEM (n = 3). *p < 0.05, **p < 0.01, ***p < 0.005 by Dunnett’s
test.
(F) HEK293 cells were pre-treated with sugar-free medium for 24 hr followed by re-feeding 0.3 mM galactose for indicated
times. Actin was monitored as a loading control. Cells were cultured under serum-free conditions.
See also Figures S1–S3.
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that generated XBP1s mRNA, albeit very weakly (Figure S6D) (Tsuru et al., 2016). The XBP1 splicing ap-
peared to occur without inducing conspicuous IRE1a phosphorylation. This observation may be explained
as follows: the increased IRE1a protein might weekly oligomerize by itself and induce self-phosphorylation,
but the phosphorylation levels were very weak and below the detection levels of the antibody used. Over-
expression of XBP1s, but not ATF4 or ATF6, clearly upregulated the protein levels of N-glycosylation-
related genes, except for STT3A (Figure 2E). We also found that XBP1 knockdown significantly diminished
the upregulation of the N-glycosylation-related mRNAs in response to sugar deprivation (Figure 2F).
Furthermore, XBP1s production, induced by sugar deprivation, was inhibited by the addition of galactose
in a dose-dependent manner (Figure 2G). Consistent with these results, the addition of a trace amount of
galactose dose dependently suppressed the upregulation of theN-glycosylation-relatedmRNAs that were
induced by sugar deprivation (Figure 2H).
Accumulation of F6P in Galactose(+) Condition
We then questioned whether added galactose is metabolized via the Leloir pathway to activated nucleo-
tide sugars and is used in the mature N-glycosylated proteins, such as laminin b2. We then observed that
[14C]galactose was indeed incorporated in mature laminin b2 (Figure 3A), demonstrating that the added
galactose is incorporated as a carbon source into sugar chains of laminin b2.
We next measured the extracellular acidification rate (ECAR) and oxygen consumption rate (OCR). Glucose
or mannose immediately increased ECAR, leading to a compensatory decrease of OCR. In contrast, galac-
tose did not alter ECAR or OCR at all (Figure 3B). Rotenone, a complex I inhibitor, decreased OCR with all
indicated sugar conditions. Decreased OCR induced a compensatory increase of ECAR in glucose(+) or
mannose(+) medium, but not in galactose(+) medium (Figure 3B).
Given that galactose did not affect ECAR despite entering the glycolytic pathway, we expected that in the
galactose(+) medium the glycolytic pathway may arrest, and then the corresponding metabolites would
accumulate somewhere within the glycolytic pathway. We therefore performed a metabolome analysis
with capillary electrophoresis time-of-flight mass spectrometry (CE-TOFMS) to evaluate metabolite levels
in HEK293 cells treated with sugar-free, 3 mM glucose, and 3 mM galactose for 6 hr (Figure 3C). In the
sugar-free condition, levels of metabolites just upstream of dihydroxyacetone phosphate (DHAP) were
essentially undetectable, e.g., glucose-1-phosphate (G1P), G6P, F6P, and fructose-1, 6-bisphosphate (Fig-
ure 3C). In the glucose(+) condition, the metabolites upstream of F6P appeared to be rapidly metabolized
in the glycolytic pathway (Figure 3C). By contrast, in the galactose(+) condition, metabolite levels upstream
of F6P dramatically increased, when compared with the sugar-free and the glucose(+) conditions. Consis-
tent with the results of flux analyses (Figure 3B), in the galactose(+) condition, the amount of lactic acid,
which reflects the ECAR, was comparable to that in the sugar-free condition, and was much lower than
the amount of lactic acid in the glucose(+) condition (Figure 3C).
The level of UDP-GlcNAc even in the sugar-free condition was similar to those in the other two conditions
(Figure 3C), and cells cultured in the sugar-free condition for a much longer time (e.g., 72 hours) retained
the N-GlcNAc2 modifications (Figure S7A), indicating that UDP-GlcNAc is mostly supplied by its re-usage
Figure 2. Galactose Cancels the Upregulation of N-Glycosylation-Related Genes Induced by Spliced XBP1
(A–C) Quantification of indicated gene transcripts by qRT-PCR. HEK293 cells were deprived of sugar for 24 hr, and gene transcripts in the glycolytic pathway
(A), in the hexosamine biosynthetic pathway (B), and of the catalytic subunits of theN-oligosaccharyltrasferase complex (C) were analyzed. The values are the
mean G SEM (n = 3–6). N.D., not detected. *p < 0.05, **p < 0.01 by Student’s t test.
(D–F) Spliced XBP1 (XBP1s) increases glycosylation-related genes. (D) HEK293 cells were transfected with mock (white bars), ATF4 (red bars), ATF6 (yellow
bars), or XBP1s (green bars) cDNA expression vectors, and cultured in 25 mM glucose condition for 24 hr. The expression levels of the indicated genes were
measured by qRT-PCR, relative to the mock control, which was arbitrarily set as 1. Mannose phosphate isomerase (PMI) was included as a negative control.
(E) HEK293 cells were transfected with FLAG-XBP1s and cultured in medium containing 25 mM glucose for 24 hr. Total cell lysates were analyzed by western
blot. (F) Effect of XBP1 knockdown on indicatedN-glycosylation-related gene expression in HEK293 cells treated with or without sugar deprivation for 24 hr.
GRP78 as well as CHOP and IRE1a were used as positive and negative controls, respectively. The values are the meanG SEM (n = 3–6). N.S., not significant.
*p < 0.05, **p < 0.01, ***p < 0.005 by Dunnett’s test.
(G) XBP1 splicing assay. RNAs from HEK293 cells treated with the indicated conditions for 24 hr were examined by RT-PCR.
(H) Galactose effects on the expression of N-glycosylation-related genes were analyzed by qRT-PCR. HEK293 cells were treated in conditions described in
(G). PMI was used as a negative control. The values are the meanG SEM (n = 3–6). *p < 0.05, **p < 0.01 by Dunnett’s test. Cells were cultured under serum-
free conditions.
See also Figures S4–S6, Tables S1 and S2.
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Figure 3. Alteration of Metabolism in Response to Galactose
(A) Incorporation of [14C]galactose into laminin b2. HEK293 cells were transfected with mock or a C-terminal His-tagged
laminin b2 expression construct, and were then cultured in medium with or without 0.3 mM [14C]galactose for 24 hr.
Immunoprecipitates with His antibody were analyzed by silver staining, western blot, and autoradiography.
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in the cells (Rome and Hill, 1986), but not by HBP. Consistently, cells cultured with azaserine or 6-diazo-
5-oxo-1-norleucine, both of which are HBP inhibitors, were unaffected with regard to the maturation of
N-glycosylated proteins or the abatement of ER stress in the presence of glucose or galactose (Figure S7B).
These results further support the idea that accumulated F6P in the galactose(+) condition is preferentially
utilized to produce GDP-Man for the maturation of high-mannose-type glycoproteins. It is notable that
addition of bafilomycin A1 or E64d/pepstatin A, each of which is an inhibitor of autophagy, did not affect
the maturation of N-glycosylated proteins by galactose (Figure S7C). These results appear to rule out the
involvement of autophagy in the maturation of N-glycosylated proteins by galactose.
We next investigated whether galactose affects the expression level of phosphofructokinase 1 (PFK1), but the
expression levels of PFK1 in the HEK293 cells were almost identical among all conditions (Figure 3D). We then
compared PFK1 activity among the conditions. Interestingly, we found that PFK1 activity increased in parallel
with the glucose concentrations of culture medium, and galactose was unable to activate PFK1 (Figures 3E
and 3F). On the other hand, the PFK1 activity was not inhibited by the addition of galactose or galactosemetab-
olites, e.g., galactose-1-phosphate and UDP galactose (Figure 3G). Taken together, these results indicate
that galactose does not stimulate the PFK1 activity, leading to the accumulation of galactose-derived F6P.
A Trace Amount of Galactose Reduces ER Stress and Cell Death in Sugar Deprivation
Next, we investigated the effects of glucose or galactose on the prevention of cell death induced by sugar
deprivation. Supplementation with 3 and 25 mM glucose increased cell proliferation in a dose-dependent
manner (Figure 4A). However, 0.3 mM glucose showed no effect on cell proliferation or protection, when
compared with the sugar-free condition. In contrast, 0.3 mM galactose dramatically induced cell prolifer-
ation. With 3 mM galactose, cell proliferation slightly decreased, compared with 3 mM glucose or 0.3 mM
galactose. These observations may reflect a condition of patients with galactosemia, having a milieu of
symptoms including cataracts, liver, and brain growth failure (Lai et al., 2009).
A Trace Amount of Galactose Promotes Growth Signal Transduction via the Maturation of
Protein Glycosylation
Based on the evidence that many growth factors and their receptors are glycoproteins (Takahashi et al.,
2004; Kaszuba et al., 2015), we examined the protein status of growth factor receptors, such as epidermal
growth factor (EGF) receptor (EGFR) and insulin growth factor (IGF) receptor (IGFR). In the sugar-starved
conditions, maturation of EGFR was clearly inhibited, and protein levels of IGF1Rb were greatly reduced
(Figure 4B). Mature and immature EGFR and IGF1Rb were mainly detected in the membrane fraction (Fig-
ures 4C–4E). However, in the starved condition, responses of cells to EGF, IGF, and serum were reduced,
which was evidenced by the absence of ERK phosphorylation (Figures 4F–4H). Addition of a trace amount
of galactose, namely, 0.3 mM galactose, was able to correct these abnormalities. By contrast, these abnor-
malities were not corrected by the addition of 0.3 mM glucose (Figures 4F–4H).
DISCUSSION
Animals must overcome various environmental challenges. Among them, starvation might be common but
most dangerous, and thus animals should be equipped to cope with such potentially fatal conditions. Star-
vation, especially sugar deprivation, has been known to induce ER stress, which is evidenced by the
Figure 3. Continued
(B) The response of ECAR (upper panel) and OCR (lower panel). HEK293 cells were stimulated with glucose (3 mM),
mannose (3 mM), or galactose (3 mM), and subsequently subjected to the mitochondria inhibitor rotenone (3 mM) and the
glycolysis inhibitor 2-DG (100 mM) at the indicated times. Both datasets are from the same experiment, and each data
point represents the mean G SEM, n = 4.
(C) Metabolomic analysis of HEK293 cells treated with sugar-free (white), glucose (3 mM, red), and galactose (3 mM,
green) conditions for 6 hr. The relative quantities of the annotated metabolites are represented as bar graphs.
(D) Representative immunoblot of PFKP in response to the indicated treatments.
(E) HEK293 cells were treated with the indicated conditions for 6 hr, and PFK1 activity was analyzed by measuring NADH
consumption.
(F) HEK293 cells were sugar-deprived (SD) for 6 hr, followed by restoration with the indicated sugars (3 mM each) for 1 hr.
(G) HEK293 cells were cultured in medium containing glucose (3 mM) for 6 hr, and PFK1 activity was analyzed in a reaction
mixture that included galactose (Gal) (3 mM), galactose-1-phosphate (Gal-1P) (3 mM), or UDP galactose (UDP-Gal)
(3 mM). The data are the meanG SEM. ***p < 0.005 by Dunnett’s test. Cells were cultured under serum-free conditions.
See also Figure S7.
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Figure 4. A Trace Amount of Galactose Promotes Cell Survival and Growth as well as Maturation of Growth Factor Receptors
(A) Photographs of HEK293 cells, cultured with sugar-free, glucose, or galactose conditions for 48 hr, starting from cells at 70% confluency in each well of a
6-well plate at time 0 (left). Live cell numbers were counted by staining with trypan blue (right). The data are the mean G SEM (n = 3). Scale bar, 50 mm.
(B) Expression of IGF1Rb and EGFR. HEK293 cells were treated with the indicated conditions for 24 hr, and whole-cell lysates were analyzed by western blot.
(C–E) Cell fractionation to examine glycoproteins after growth in mediumwith (C) 25 mMglucose, (D) sugar-free, or (E) 0.3 mM galactose. Antibodies against
EGFR, IGF1Rb, and laminin g1 were as in (B), and MEK1/2 and histone H3 were markers for the cytoplasmic and nuclear fractions, respectively.
(F–H) ERK activation by extracellular stimulation. HEK293 cells were cultured with the indicated conditions without serum for 24 hr before stimulation with 5%
serum for 5 min (F), 50 ng/mL IGF1 for 10 min (G), or 50 ng/mL EGF for 5 min (H). Western blot analysis detected phosphorylated and total ERK levels under
different conditions of sugar supplementation, as indicated. Actin was used as a loading control. Cells in (B–H) were cultured under serum-free conditions.
218 iScience 10, 211–221, December 21, 2018
induction of CHOP and GRP78 proteins. In this study, we observed the production of immature glycosyl-
ation forms of high-mannose-type glycoproteins, which were recognized by CTD110.6 antibody in
sugar-starved cultured cells (Isono, 2011). Given that levels of GDP-Man decrease under sugar starvation,
and that the molecule recognized by CTD110.6 antibody is N-GlcNAc2 (Isono, 2011), addition of mannose
to dolichol-pyrophosphate-GlcNAc2 (Dol-PP-GlcNAc2) by b-1,4 mannosyltransferase-1 (ALG1) (Couto
et al., 1984) would not occur. Thus ALG1 functions as the sensor to monitor the levels of GDP-Man in
the cells; when the levels of GDP-Man become much lower than the KD value, any addition of mannose
to Dol-PP-GlcNAc2 would cease. In this scenario, mammalian cells utilize such naked Dol-PP-GlcNAc2,
instead of mature glycans, as the substrate of OST to produce immature glycoproteins. As the presence
of such immature glycoproteins appeared to be intimately coupled with the evocation of ER stress, cells
appear to engage a system to induce an ER stress response via the production of immature glycoproteins
under starvation. Consistently, we were able to show that ER stress leads to the expression of HK2, GFAT1,
and GMPP, essential enzymes involved in the synthesis ofN-glycosylation components (e.g., UDP-GlcNAc,
GDP-Man), and that XBP1s is responsible for their expression. It is noteworthy that UDP-GlcNAc and GDP-
Man are also utilized in O-glycosylation (Spiro, 2002). Therefore, it is also expected that maturation of not
only N-glycosylated but also O-glycosylated proteins is also hindered under sugar starvation and that
maturation of both N- and O-glycosylated proteins is also restored by a trace amount of galactose.
Other ER stress inducers, e.g., thapsigargin and brefeldin A, which are not related to the production of
immature glycoproteins, also induce HK2, GFAT1, GMPPA, GMPPB, and STT3A mRNAs and the corre-
sponding proteins, indicating that the response to immature glycoproteins is a fundamental, perhaps
archetypical ER stress response.
We demonstrated that galactose is much more potent to maintain matureN-glycosylation of proteins than
glucose and mannose. Maintenance of mature N-glycosylation contributes to the relief of starvation-
induced ER stress and cell death and also to appropriate growth-factor-mediated signal transduction.
From our metabolome data, under the galactose(+) condition accumulation of galactose-derived F6P
was observed, which would be utilized in the production of nucleotide sugars required forN-glycosylation.
However, such F6P accumulation was not observed in the glucose(+) condition. It is notable that galactose
itself is utilized in other types of glycosylation. These observations indicate that galactose frommilk or milk
sugar would preferentially contribute to produce mature glycoproteins rather than to energy production
during starvation. It is obvious thatmalnutrition affects thegrowth of infants. Furthermore, it has been shown
that newborn babies experience what can be considered to be seriously starved conditions at birth (Burns
et al., 2008; Adamkin and Committee on Fetus and Newborn, 2011), and that to survive these conditions,
autophagy and milk play crucially important roles for the supply of nutrients as energy sources (Kuma
et al., 2004). Our results indicate that milk, as a sugar source, is also necessary for the maturation of glyco-
proteins, which in turn contribute not only to the prevention of ER stress and cell death in many organs but
also to the maintenance of growth-factor-mediated signaling for the normal post-natal growth of infants.
Limitations of the Study
The study was conducted only in cultured mammalian cells. Therefore, for the substantiation of the bene-
ficial functions of galactose during starvation in vivo, it will be necessary to perform animal experiments,
examining both cellular and overall responses under similar conditions.
METHODS
All methods can be found in the accompanying Transparent Methods supplemental file.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Transparent Methods, seven figures, and two tables and can be found
with this article online at https://doi.org/10.1016/j.isci.2018.11.035.
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Figure S1. Identification of N-GlcNAc2-Modified Proteins under Sugar-Free 
Conditions, Related to Figure 1. 
(A) HEK293 cells were cultured in high-glucose medium (25 mM) or sugar-free 
medium (0 mM glucose) for 24 h. Proteins immunoprecipitated with CTD110.6 
antibody were visualized on silver-stained gels. Laminin β2, Laminin γ1, and a non-
specific signal (#) are shown. (B) HEK293 cells were treated as in Figure 1A, and anti-
Laminin β2 or anti-Laminin γ1 immunoprecipitates were analyzed by western blotting 
with indicated antibodies. (C) HEK293 cells were grown with high-glucose medium, 
then deprived of glucose for 24 h. During this time, 3 mM glucose was added back to 
the medium for the indicated total times; thus, “24” indicates that glucose was added 
back to the medium immediately and remained in the medium over the full 24 h of 
subsequent growth, whereas “3” indicates that glucose was added back to the medium 
only 3 h before harvest. Western blots of cell lysates were probed with CTD110.6, anti-
Laminin γ1, and anti-actin antibodies. Cells were cultured under serum-free conditions.  
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Figure S2. N-GlcNAc2-Modified Laminin β2 is a Newly Synthesized Product, 
Related to Figure 1.  
HEK293 cells were transfected with mock or C-terminal 6×His-tagged Laminin β2. At 
24 h post-transfection, cells were cultured in serum-free medium containing 50 μCi of 
[35S]methionine/cysteine (PerkinElmer) for 4 h. Following the pulse-labeling, cells were 
subjected to sugar deprivation for 8 h. Immunoprecipitates pulled down with an anti-











Figure S3. Galactose Preferentially Promotes Protein N-Glycosylation over 
Glucose in Low-Sugar Conditions in HepG2 and PC12 cells, Related to Figure 1. 
The effect of limiting amounts of galactose or glucose on N-glycosylation of Laminin 
γ1, and the ER stress marker CHOP, in HepG2 (A) and PC12 cells (B). In A and B, 
each immunoblot shows the Laminin γ1 cellular N-glycosylation level and CHOP as ER 
stress marker. The arrow indicates an immature lower molecular weight Laminin γ1 in 
HepG2 cells. Data are representative of three independent experiments. Photographs of 
HepG2 (C) and PC12 cells (D), cultured with the indicated concentrations of glucose or 
galactose for 8 h and 30 h, respectively. In PC12 cells, the culture medium was 
replaced with 50 ng/mL neurite growth factor in low-glucose DMEM with 1% FBS and 
1% HS for 24 h prior to treatment. Scale bar, 50 μm. Cells were cultured under serum-




Figure S4. Expression Levels of N-Glycosylation-Related Proteins in HEK293 
Cells, Comparing 25 mM Glucose to Sugar-Free Medium, Related to Figure 2. 
Expression levels of proteins related to sugar-free upregulated mRNA levels (see 
Figures 2A-2C) were analyzed by western blotting using the indicated antibodies (left 
panels). Cells were cultured under serum-free conditions. Quantitative analysis of the 
protein levels normalized to actin is shown (right panels). The data are the mean ± SEM 






Figure S5. The ER Stress Inducers Thapsigargin and Brefeldin A also Upregulate 
N-Glycosylation-Related Genes, Related to Figure 2. 
(A) RT-qPCR analysis of N-glycosylation-related genes in HEK293 cells after 
treatment with 0.1% DMSO (Cont, white color), 1 μM thapsigargin (Tg, black color) or 
3 μg/mL brefeldin A (BFA, grey color) for 24 h. PMI was used as a negative control. 
(B) Western blotting showing the levels of N-glycosylation-related proteins under the 
treatment conditions described in (A). Cells were cultured under serum-free conditions. 
Quantitative analysis of protein levels normalized to actin is shown (right panels). The 





Figure S6. Expression of XBP1 was Induced by the Forced Expression of ATF4 or 
ATF6, Related to Figure 2.  
(A and B) HEK293 cells were transfected with Mock and FLAG-ATF4 (A) or FLAG-
ATF6 (B) for 24 h. The amount of XBP1 was determined by RT-qPCR. The data are the 
mean ± SEM (n = 3). * P < 0.05, ** P < 0.01 by Student’s t test. (C) HEK293 cells 
were transfected with empty (Mock), ATF4-, or an ATP6-expression vector and 
cultured for 48 h, followed by a 12h treatment with 0.1% DMSO or thapsigargin (Tg). 
Cell lysates were then subjected to western blotting analysis with the indicated 
antibodies. (D) Confirmation of overexpression efficacy of ATF4 or ATF6 in HEK293 




Figure S7. Maturation of Glycoproteins by Galactose is Independent of 
Autophagy, Related to Figure 3. 
(A) Western blotting analysis of HEK293 cells cultured in the absence of sugar for the 
indicated times. Each immunoblot was probed with CTD110.6, anti-Laminin γ1, or 
anti-actin antibodies. (B) HEK293 cells cultured in medium containing 3 mM glucose 
or 3 mM galactose with or without HBP inhibitors (1 mM DON or 1 mM AZA) for 24 h 
were harvested, and then cell lysates were subjected to western blotting analysis with 
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the indicated antibodies. (C) HEK293 cells were cultured in glucose-free medium for 24 
h, and then treated with medium containing 3 mM glucose or 3 mM galactose with or 
without autophagy inhibitors for 12 h. Inhibitors were bafilomycin A1 (1 μM, a 
lysosomal acidification inhibitor) and E64d/pepstatin A (10 μM each, both of which are 
lysosomal proteases inhibitors). Cell lysates were then analyzed by western blotting 
with the indicated antibodies. The conversion of LC3-I to LC3-II indicates autophagic 















Gene Forward sequence (5' - 3')  Reverse sequence (5' - 3')  
Hexokinase 1 (HK1)  AGGTGAAGAAGAGGATGCGG CGAAGGAGGGCAGCATCTTAAC 
Hexokinase 2 (HK2)  GAGGATGAAGGTAGAAATGGAGCGA GTAGCACACACGTAGGTGGG 
Glucokinase (HK4)  CTACTACGAAGACCATCAGTGCGA CATTCTGCATCTCCTCCATGTAGC 
Glucose-6-phosphate isomerase (GPI) GATGGACCAGCACTTCCGCA TCTCACACCCAAAGCAGTTGAT 
Phosphofructokinase, liver (PFKL) TGACAAGAGGTTTGACGAGGCCA TGGGCGAGGAGCTTGTAAAT 
Phosphofructokinase, muscle (PFKM) CCTGTGTAGTGAGCCTCTCTGGTAA TCAGCTTCAGGGCTTCGTCAA 
Phosphofructokinase, platelet (PFKP) CGTGCAGATGACTCAGGATGT TTGATGGCAAGTCGCTTGTAGG 
Aldolase, fructose-bisphosphate A (ALDOA) CGCAGGAGGAGTATGTCAAGC ATAGGCGTGGTTAGAGACGAAGA 
Aldolase, fructose-bisphosphate B (ALDOB) GCTGCAAACAAGGAGGCAAC CTGTGAAGAGCGACTGGGTG 
Aldolase, fructose-bisphosphate C (ALDOC) CTTACCTTCTCCTATGGGCGTG CGCTTGATGAACTCCTCAGTGG 
Triosephosphate isomerase 1 (TPI1) AGCAGACAAAGGTCATCGCAGATAA GGGTGTTGCAGTCTTGCCAGTA 
Glyceraldehyde-3-phosphate dehydrogenase 
(GAPDH)  CCTGCACCACCAACTGCTTA CAGTGATGGCATGGACTGTG 
Phosphoglycerate kinase 1 (PGK1) TCCGAGCTTCACTTTCCAAGCTA TTCTGTGGCAGATTGACTCCTACC 
Phosphoglycerate kinase 2 (PGK2) CCGGATTCTTGATGAAGAAGGAAC CTTGTCTGCCACTTTGGCTC 
Phosphoglycerate mutase 1  (PGAM1) GGAGGCGCTCCTATGATGTC TCTTCTGTGAGGTCTGCATACCTG 
Phosphoglycerate mutase 2  (PGAM2) ACAGGCCTCAACAAGGCAGAAA CCTTGCTAATGGAGTTGTAGTAGGG 
Enolase 1 (ENO1) AGAGGTTTACCACAACCTGAAGAAT TCTCCAGGATGTTGGGAGCA 
Enolase 2 (ENO2) CAGTGGGAGCTGAGAGCTTT GTGGCATCCTTGCCGTATTTG 
Enolase 3 (ENO3) GAGAACAATGAGGCCCTGGAG AAGATCGTACTTCCCATTGCGATAG 
Enolase 4 (ENO4) CGAGATGCTTATGGAAATGCAGAA AGTGATCTGCTGTTGACCTCTT 
Lactate dehydrogenase A (LDHA) AATTTGGTCCAGCGTAACGTGA ATCTTCCAAGCCACGTAGGT 
Lactate dehydrogenase B (LDHB) CTAAGTGGATTACCCAAACACCGC CTGCTGGGATGAATGCCAAG 
Pyruvate kinase-Muscle (PKM2) GGGTCGAGCAGGATGTTGATATG ATGTTCTTTCCCTTCTCTCCCAG 
Pyruvate kinase-Liver and RBC (PKLR) GAAATCCTGGAGGTGAGCGAC GCCCAATCATCATCTTCTGAGCC 
Mannose phosphate isomerase (PMI) TTCCGGCCAGTTGAGGAGATTGTAA TCATGGCTCATGGTCTGCTT 
Phosphomannomutase 1 (PMM1) TTATGTGTTTGCCGAGAACGGG CCAGGTGGTTCTGGATGGTC 
Phosphomannomutase 2 (PMM2) AGAAGAACGCATTGAGTTCTACGA GCAAACTCTTTCCGTAGATCTGCT 
Glutamine--fructose-6-phosphate 
transaminase 1 (GFAT1)  ATATTTGAGCAGCCAGAGTCTGTC CCTTTATGTGATCCTTCAAACCACC 
Glutamine--fructose-6-phosphate 
transaminase 2 (GFAT2)  ATACTATGAGAGGTCGGGTGAATTT AACCATCACAGGAAGCTCAGTC 
GDP-mannose pyrophosphorylase A 
(GMPPA) AAACCCAGCACATTTATCAGTGAC TGCCCATCCTGCTGATTACG 
GDP-mannose pyrophosphorylase B 
(GMPPB) GAGGAACCCTCCAAGTACGG GCCTGCGTTGATCTTATTGGAC 
Stt3a, subunit of the 
oligosaccharyltransferase complex (STT3A) AGCTCCTCGTCTTCATGTTTCC AGACTCCAATGCCAGAGAGAAT 
Stt3b, subunit of the 
oligosaccharyltransferase complex (STT3B) TGCAGGTGCTGTGTTCCTTAG  CCCAAGTCGTAGGTTGATGCTC 
DNA damage inducible transcript 3 (CHOP) CCAGCAGAGGTCACAAGCAC ACTCTGTTTCCGTTTCCTGGTT 
Heat shock protein family A (Hsp70) member 
5 (GRP78) CAACATGGATCTGTTCCGGTC TTGGAATTCGAGTCGAGCCAC  
X-box binding protein 1 (XBP1) TTACGAGAGAAAACTCATGGCC GGGTCCAAGTTGTCCAGAATGC 
eukaryotic translation initiation factor 2 
alpha kinase 3 (PERK) CATCCTCATCCTCACAGGCAAAG TCATTCCAGCTACTGTCATTGGC 
endoplasmic reticulum to nucleus signaling 1 
(IRE1) GGTGGCCTTCATCATCACCTAT CTGCAGGAGCTGGATCTTCT 
activating transcription factor 6 (ATF6) CACCCACTAAAGGCCAGACG CGTGATTAGGGAGCTGTGTGAC 






Cell Cultures and Plasmid Transfection  
HEK293 and HepG2 cells were cultured in high-glucose Dulbecco’s modified Eagle’s 
medium (DMEM, Nacalai Tesque), and supplemented with 10% fetal bovine serum 
(FBS) at 37ºC in 5% CO2. PC12 cells were maintained in low-glucose DMEM (5.6 mM 
glucose) with 10% FBS and 5% horse serum. Cells were initially seeded in each 
medium, washed once with PBS and cultured in DMEM without glucose (Nacalai 
Tesque, referred as “sugar-free”) supplemented with various concentrations of 
monosaccharides (glucose, mannose, and galactose) without FBS. When needed, 
HEK293 cells were transfected with expression plasmids using Lipofectamine LTX 
with Plus reagent (Invitrogen), according to the manufacturer's protocol.  
 
Construction of Expression Vectors  
Mouse full-length ATF4, ATF6, and spliced XBP1 (XBP1s) were amplified from 
cDNA from B16F10 cells using the indicated primers (see Table S1), and subcloned 
into EcoRI-XbaI sites, ClaI-Asp718I sites, and ClaI-XbaI sites of the pFLAG-CMV2 
vector, respectively. C-terminal 6×His-tagged rat Laminin β2 was obtained by 
subcloning the cDNA insert into the pcDNA3-6×His vector.  
 
Reagents  
D-glucose, D-mannose, D-galactose, L-glutamine, sodium pyruvate, and 2-deoxy-D-
glucose (2-DG) were purchased from Nacalai Tesque. Thapsigargin (Tg) was obtained 
from WAKO. Rotenone, oligomycin, bafilomycin A1, E64d, pepstatin A, and UDP-
Galactose (UDP-Gal) were purchased from Sigma-Aldrich. Brefeldin A (BFA) and 
galactose-1-phosphate (Gal-1P) were obtained from Millipore. Azaserine (AZA) and 6-
diazo-5-oxo-1-norleucine (DON) were purchased from Santa Cruz Biotechnology. 
 
Western Blotting 
Cells were lysed in RIPA buffer (150 mM NaCl, 1% Nonidet P-40, 1% sodium 
deoxycholate, 0.1% SDS, 25 mM Tris-HCl, pH 7.6) containing a protease inhibitor 
cocktail (Roche), sonicated, and centrifuged at 15,000 ×g for 10 min. The protein 
content of supernatants was quantified using a BCA assay kit (Nacalai Tesque). Proteins 
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were separated on pre-cast 5–20% gradient polyacrylamide gels (WAKO) and 
transferred to polyvinylidene difluoride membranes (Millipore). The membranes were 
then incubated overnight with primary antibodies, described below. ECL anti-rabbit or 
anti-mouse IgG HRP-linked whole antibody (GE Healthcare, 1:2,500) was used as the 
secondary antibody, and signals were detected using ECL Western blotting detection 
reagent (GE Healthcare) and ImageQuant LAS4000 (GE Healthcare). Protein bands 
were quantified by densitometry analysis using ImageJ software. Actin was used as a 
loading control.  
 
Antibodies 
Antibodies against Laminin γ1 (sc-5584) and CHOP (sc-793) were purchased from 
Santa Cruz Biotechnology. Laminin β2 antibody (C4) was kindly provided by Dr. 
Kikkawa (Tokyo University of Pharmacy and Life Sciences, Japan). Antibodies against 
HK2 (C64G5), GRP78 (C50B12), MEK1/2 (47E6), Histone H3 (D1H2), ERK (9102), 
phospho-ERK (9101), IRE1α (14C10), EGFR (D38B1), and IGF1Rβ (D23H3) were 
purchased from Cell Signaling. Antibodies against GFAT1 (EPR4854), PMI 
(EPR10234), phospho-IRE1α (EPR5253), and PFKP (1D6) were obtained from Abcam. 
The antibody against actin (clone C4) was from Chemicon. Anti-O-GlcNAc 
(CTD110.6) antibody was obtained from Covance. Anti-His (OGHis) and anti-LC3 
(PM036) antibodies were purchased from MBL. Anti-GMPPA (15517-1-AP), anti-
GMPPB (15094-1-AP), and anti-STT3A (12034-1-AP) antibodies were obtained from 
Proteintech. Anti-FLAG (M2) antibody was purchased from Sigma-Aldrich.  
 
Immunoprecipitation 
HEK293 cells were lysed in lysis buffer (150 mM NaCl, 1% Nonidet P-40, 5% 
glycerol, 1 mM EDTA, 25 mM Tris-HCl, pH 7.4) containing protease inhibitor cocktail 
and incubated for 2 h at 4ºC with CTD110.6 antibody (1:1,000), Laminin γ1 antibody 
(1:1,000), or Laminin β2 antibody (1:1,000). The immunocomplexes were bound to 
Protein A/G PLUS-agarose (Santa Cruz) overnight at 4ºC and washed five times with 
TBS. For LC-MS/MS analysis, the immunocomplexes were eluted with 0.1 M glycine-
HCl (pH 3.0) and immediately neutralized with 2 M Trizma base, and for other 
experiments the immunocomplexes were eluted with 1× SDS sample buffer and heat-
denatured at 90ºC for 5 min. 
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LC-MS/MS Analysis and Identification of N-GlcNAc2 Modified Proteins  
To identify the CTD110.6-interacting bands, gels were silver-stained using Sil-Best 
Stain One (Nacalai Tesque) and immunoblotted with CTD110.6 antibody. Each 
identified band was digested in the gel by modified trypsin (Promega). The extracted 
samples were analyzed by LC-MS/MS using an LTQ mass spectrometer (Thermo 
Fisher Scientific) combined with Paradigm MS4 HPLC (Michrom BioResources). Both 
MS and MS/MS spectra were searched against the Mascot database (Matrix Science) to 
identify the proteins. 
 
RT-qPCR  
Total RNA was isolated from cells using the SV total RNA isolation kit (Promega). For 
cDNA synthesis, total RNA (1 μg) was reverse transcribed using ReverTra Ace qPCR 
RT Master Mix with gDNA Remover (TOYOBO), according to the manufacturer's 
protocol. qPCR was performed on a LightCycler PCR System (Roche Diagnostics) and 
carried out at 98ºC for an initial 2 min followed by 45 cycles of denaturation at 98ºC for 
10 sec, annealing at 60ºC for 10 sec, and extension at 68ºC for 30 sec using KOD 
SYBR qPCR Mix (TOYOBO). Primer sets are listed in Table S2. Primers were 
designed and selected with the use of LightCycler Probe Design software 2.0 (Roche 
Applied Bioscience). The GAPDH was used as an internal control for normalization of 
target gene expression.  
 
XBP1 splicing assay 
To assess the variant XBP1 by PCR, sequence of the primers were used as same as 
qPCR, corresponding to nucleotides 428-449 and 689-710 of the human XBP1 cDNA 
generating two PCR products of 283 (unspliced XBP1, XBP1u) and 257 (spliced XBP1, 
XBP1s) base pairs. Cycling condition was carried out at 95ºC for an initial 30 sec 
followed by 28 cycles of denaturation at 95ºC for 10 sec, annealing at 60ºC for 10 sec 
and extension at 72ºC for 5 sec using PrimeSTAR Max DNA polymerase (TaKaRa). 






RNA Interference  
siRNAs for PERK (s18102), IRE1 (s200430), ATF6 (s22688), and XBP1 (s14913) were 
obtained from Ambion (LifeTechnologies) using the Silencer Select siRNA series. 
Target siRNA or control siRNA (Silencer Select Negative Control No.1 siRNA; 
Ambion) was transfected into HEK293 cells using Oligofectamine (Invitrogen) in each 
well of 6-well plates following the manufacturer’s instructions. The cells were cultured 
for 72 h prior to use in the knockdown experiments. .  
 
ECAR and OCR Measurements  
ECAR and OCR were measured using the Seahorse XF96 Flux Analyzer in accordance 
with the manufacturer’s instructions (Seahorse Bioscience, USA). The XF96 microplate 
was coated with type I collagen (Nitta Gelatin) and left for at least 1 h at room 
temperature. Briefly, cells were seeded in a microplate in the corresponding cell growth 
medium and then incubated at 37ºC in 5% CO2 for 24 h. Before changing the assay 
medium, cells were exposed to sugar-free conditions for 3 h. Assays were initiated by 
replacing the medium with 175 μL assay medium supplemented with 4 mM glutamine 
and without sugars. The microplates were incubated at 37ºC for 2 h to equilibrate the 
temperature and pH of the media before measurement. After incubation, the plate was 
loaded on the analyzer. The concentrations of compounds sequentially added to the 
medium (175 μL) of the cell plate during the course of the experiment were 24 mM 
sugar, 27 μM rotenone, and 1 M 2-DG in volumes of 25 μL each, resulting in final 
concentrations of 3 mM sugar, 3 μM rotenone, and 100 mM 2-DG, respectively. The 
final injection was 2-DG, a glucose analog, which inhibits glycolysis through 
competitive binding to glucose hexokinase, the first enzyme in the glycolytic pathway. 
All values of ECAR and OCR were normalized to cell number. Data shown are the 
representative mean ± SEM from three independent experiments. 
 
Carbon-14 Labeling Study  
D-[1-14C]galactose (PerkinElmer) was used for labeling sugar chains on 6×His-tagged 
Laminin β2. Cells transfected with mock or a 6×His-tagged Laminin β2 expression 
construct were plated in 6-well plates, and maintained for 24 h. When cells were 100% 
confluent, the medium was changed to sugar-free medium or 0.3 mM [1-14C]galactose 
medium for 24 h. After cells were harvested and lysed, 6×His-tagged Laminin β2 was 
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pulled down using a His-tagged Protein PURIFICATION KIT (MBL), followed by 
SDS-PAGE and autoradiography. Detection of the labeled Laminin β2 by 
autoradiography was performed using an FLA7000 image analyzer (Fujifilm). 
 
Metabolomic Analysis  
HEK293 cells were seeded in three 10 cm dishes and incubated in growth media until 
they reached 90% confluence, then treated with medium that was sugar-free, or 
supplemented with 3 mM glucose or 3 mM galactose, for 6 h. The respective media 
were removed from the plates, and cells were washed twice with 5% mannitol solution 
(10 mL first and then 2 mL), treated with 800 μL of methanol (WAKO), and let stand 
for 30 sec. The cell extract was then treated with 550 μL of Milli-Q water containing 
internal standards (Human Metabolome Technologies (HMT)) and let stand for another 
30 sec. The extract was obtained and centrifuged at 2,300 ×g and 4ºC for 5 min, and 
then 800 μL of the upper aqueous layer was centrifugally filtered through a Millipore 5-
kDa cutoff filter (UltrafreeMC-PLHCC, HMT) to remove macromolecules (9,100 ×g, 
4ºC, 120 min). The filtrate was centrifugally concentrated and resuspended in 50 μL of 
Milli-Q water for metabolome analysis at HMT and analyzed by a CE-TOFMS system 
(Agilent Technologies). Signal peaks were annotated according to the HMT metabolite 
database based on their m/z values with the migration times. Detected metabolites were 
plotted on metabolic pathway maps using VANTED software.  
 
Spectrophotometric PFK1 Activity Assay  
PFK1 activity was measured with slight modifications to the described procedure (Deng 
et al., 2008). Cells were washed with 1 × PBS, pH 7.4, and incubated in lysis buffer (50 
mM Tris–HCl, pH 7.5, 1 mM EDTA, 150 mM NaCl, 1% Nonidet P-40, 0.5 mM DTT, 
protease inhibitor cocktail) for 10 min on ice. Briefly, the assay was performed by 
adding 5 μg cell lysate to 100 μL of reaction buffer containing 50 mM Tris-HCl pH 7.5, 
100 mM KCl, 5 mM MgCl2, 1 mM ATP, 0.2 mM NADH (Nacalai Tesque), 5 mM 
Na2HPO4, 0.1 mM AMP, 1 mM NH4Cl, 5 mM fructose-6-phosphate, 5 units/mL of triose 
phosphate isomerase (Sigma-Aldrich), 1 unit/mL of aldolase (Sigma-Aldrich), and 1 
unit/mL of α-glycerophosphate dehydrogenase (Sigma-Aldrich). The mixture was 
incubated at room temperature, and absorbance at 340 nm, which reflects the NADH 
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concentration, was determined each minute for up to 20 min using a DU640 
spectrophotometer (Beckman).  
 
Statistical Analysis  
Each experiment was conducted at least three times with consistent results. The gel or 
blot representative of each experiment is presented. The statistical significance was 
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